Regulation

The company also announced a commercialization deal with Novo Nordisk. 

The INVU pregnancy monitoring system offers an alternative to existing methods of measuring uterine activity.   

EndoArt successfully passed clinical trials, gaining China’s Innovative Device Status and FDA approval.

Canvas Dx is indicated as an aid in the diagnosis of ASD in patients between the ages 18 months and 5 years old who are at risk of developmental delay.   

The new legislation is intended to improve the safety of medical devices. 

Patient and providers are looking to remote monitoring for the future, but incentive structures fall short. 

The new safety feature will require users to set a 4-digit passcode to unlock the treadmill band. 

The system was cleared for use among individuals 12 years old and up with Type 1 or Type 2 diabetes on multiple-dose injection therapy.  

Viome has adapted its technology to search for the presence of oral squamous cell carcinoma and oropharyngeal cancer in users’ saliva samples.   

This week's top stories include the Patient ID Now coalition pushing for a national patient ID strategy, President Biden looking to lower ACA premiums and drug costs, and Accolade moving into the telemedicine space with PlushCare acquisition.